| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.7M | +55.0% | +70.2% |
| Cost of Revenue | $4.1M | +18.0% | +48.3% |
| Gross Profit | $14.5M | +70.2% | +77.6% |
| R&D Expense | $8.7M | +47.9% | +111.4% |
| SG&A Expense | $10.9M | +34.8% | +52.6% |
| Operating Income | -$9.3M | +7.9% | -27.9% |
| Pre-tax Income | -$8.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.9M | -9.0% | -55.1% |
| Accounts Receivable | $7.5M | -24.3% | +48.6% |
| Current Assets | $53.0M | -35.5% | -55.3% |
| Total Assets | $130.6M | +2.3% | -10.8% |
| Current Liabilities | $41.8M | +8.2% | +3.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.4M | — | — |
| Capital Expenditures | $580K | — | — |
| Investing Cash Flow | $31.2M | — | — |
| Financing Cash Flow | -$2.2M | — | — |
| Free Cash Flow | -$25.0M | — | — |
| +10.0% |
| -40.6% |
| Income Tax | -$3.6M | -593.0% | -2038.8% |
| Net Income | -$5.3M | +43.7% | +19.1% |
| EPS (Basic) | -$0.18 | +43.8% | +21.7% |
| EPS (Diluted) | -$0.18 | +43.8% | +21.7% |
| $51.5M |
| +7.2% |
| +7.7% |
| Stockholders' Equity | $79.1M | -0.6% | -19.8% |